Aurobindo Pharma Limited, a Hyderabad-based manufacturer of generic pharmaceuticals and active pharmaceutical ingredients (APIs), has received approval from the Medicines Control Council (MMC) to manufacture and market two more products in South Africa.
These are Auro-Ampicilin 500mg and 100mg injections and Auropidone 0.5 mg tablets that fall under the anti-infective and central nervous system categories respectively.
With these, Aurobindo now has 37 products approved by the MCC, the company said in a press release on Thursday.
Aurobindo’s scrip is currently trading at Rs 771.95 on the BSE, down 5.72 per cent as against the previous close of Rs 818.80.
